Related Experiment Videos
Interaction between methylxanthines and the benzodiazepine receptor.
Archives Internationales De Pharmacodynamie Et De Therapie
|September 1, 1983
Summary
Methylxanthines like caffeine do not significantly inhibit benzodiazepine receptors in vivo. Only toxic central nervous system effects of methylxanthines may involve the benzodiazepine receptor.
Area of Science:
- Neuropharmacology
- Biochemistry
Background:
- Benzodiazepine receptors are crucial targets for central nervous system modulation.
- Methylxanthines, including caffeine, are widely consumed psychoactive compounds.
Purpose of the Study:
- To investigate the inhibitory effects of methylxanthines on benzodiazepine receptor binding.
- To determine if methylxanthines interact with benzodiazepine receptors in vitro and in vivo.
Main Methods:
- Used 3H-Flunitrazepam to assess binding affinity.
- Tested caffeine, theophylline, theobromine, and 3-methylxanthine in rat brain homogenates.
- Evaluated inhibitory effects both in vitro and in vivo.
Main Results:
- Caffeine and theophylline exhibited low-affinity competitive inhibition in vitro.
- No significant inhibition was observed in vivo for these compounds.
- Low caffeine concentrations did not clearly inhibit low 3H-Flunitrazepam concentrations.
Conclusions:
- Methylxanthines do not appear to significantly interact with benzodiazepine receptors in vivo.
- Toxic central nervous system effects of methylxanthines might be mediated through the benzodiazepine receptor pathway.